Physician Dispensed Cosmeceuticals Market

Global Physician Dispensed Cosmeceuticals Market is valued at US$ 8.58 Billion in 2022 and expected to reach US$ 15.40 Billion by 2029 with a CAGR of 8.72% over the forecast period.

Global Physician Dispensed Cosmeceuticals Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2023-2029- Increasing demand for cosmeceuticals, rising awareness about anti-aging, and growing awareness about facial beauty enhancement are some of the major factors driving the growth of the Global Physician Dispensed Cosmeceuticals Market.

Scope of Global Physician Dispensed Cosmeceuticals Market Report-

Physician Dispensed Cosmeceuticals are specialized skincare products that are distributed and recommended by healthcare professionals, typically dermatologists, plastic surgeons, and aesthetic physicians. These products are formulated with active ingredients that have been clinically proven to provide targeted skin benefits, such as anti-aging, brightening, and rejuvenation. Physician dispensed cosmeceuticals offer a higher concentration of active ingredients compared to over-the-counter products, making them more effective in addressing specific skin concerns.

These products are often tailored to individual patient needs and are recommended after a thorough evaluation of the patient's skin condition. The physician's expertise and guidance play a crucial role in ensuring the optimal use of cosmeceuticals for achieving desired results. With their advanced formulations and professional recommendation, physician dispensed cosmeceuticals are highly regarded for their efficacy and are an integral part of comprehensive skincare regimes.

The Covid-19 pandemic has had a significant impact on the global physician dispensed cosmeceuticals market. With lockdowns, social distancing measures, and reduced consumer spending, the demand for cosmeceutical products has declined. Many aesthetic clinics and physician offices were temporarily closed or had limited operations, resulting in a decrease in the distribution and dispensing of cosmeceuticals by healthcare professionals.

Additionally, consumer preferences shifted towards essential products, and there was a decrease in elective cosmetic procedures. However, as restrictions ease and consumer confidence improves, the market is expected to rebound, albeit with changes in consumer behavior and increased emphasis on safety and efficacy.

The global physician dispensed cosmeceuticals market is segmented based on the product, application, and region & country level. Based on product, the global physician dispensed cosmeceuticals market is segmented into skincare, eye care, hair care, and others. By application, the global physician dispensed cosmeceuticals market is segmented into online sales, hospital pharmacy, and retail pharmacy.

The regions covered in the global physician dispensed cosmeceuticals market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global physician dispensed cosmeceuticals is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.

Key Players of Global Physician Dispensed Cosmeceuticals Market Report-

Some major key players for the global physician dispensed cosmeceuticals market report cover prominent players like -

• Biopelle Inc
• Jan Marini Skin Research Inc.
• La Roche-Posay
• Johnson & Johnson Consumer Inc.
• Obagi Cosmeceuticals LLC
• Clarisonic
• Solta Medical
• GlaxoSmithKline plc.
• PhytogenX Inc.
• Clinique Laboratories LLC.
• IS CLINICAL
• ALLERGAN
• others

Global Physician Dispensed Cosmeceuticals Market Segmentation:-

By Product:

• Skin Care
• Eye Care
• Hair Care
• Others

By Application:

• Online Sales
• Hospital Pharmacy
• Retail Pharmacy

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Increasing Demand for Cosmeceuticals, Rising Awareness about Anti-Aging, and Growing Awareness about Facial Beauty Enhancement are Some of the Major Factors Driving the Market Growth

One of the major factors driving the growth of the physician-dispensed cosmeceuticals market is the increasing demand for cosmeceuticals. Increased levels of stress, pollution, and climate change can cause skin, hair, and eye damage. For example; as per the Public Library of Medication data updated for "cosmeceuticals" in June 2022, beauty care products have overwhelmed the worldwide personal care market undoubtfully. It wouldn't be a misrepresentation to express that more than 30% to 40% of every dermatologist's prescriptions overall contain cosmeceuticals, despite the widespread vulnerability with respect to their definition and degree.

In addition consumers are becoming more aware of the importance of skincare and are seeking personalized solutions for their specific concerns. Physician dispensed cosmeceuticals offer targeted formulations and professional recommendations, providing a higher level of customization compared to over-the-counter products.

In addition, the rising awareness about anti-aging is also boosting the growth of the physician-dispensed cosmeceuticals market. Older people and young adults are increasingly choosing cosmeceuticals that can help them retain their youth. Dermal fillers and injectable Botox are popular beauty trends. The changing lifestyles and value systems of the population have impacted the growth of the anti-aging skincare cosmeceuticals market. This has created attractive opportunities for beauty brands offering anti-aging products. For instance; according to United Nation, in 2019, there were 703 million people in the world aged 65 years. The number of elderly populations is projected to double to 1.5 billion by 2050. Thus, the increasing elderly population has expected to drive the market growth.

Moreover, the growing awareness about facial beauty enhancement is also boosting boost the market growth. An increasing number of smartphone users are using social media to raise awareness about new brands in the physician-dispensed cosmeceuticals market. The growing influence of the online influential community on social media is emerging as an important strategy for brand building.

However, the high cost associated with physician-dispensed cosmeceuticals may hinder the growth of the global physician-dispensed cosmeceuticals market. Despite that, the growing awareness among people regarding aesthetic appeal may create more opportunities for the further growth of the global physician-dispensed cosmeceuticals market.

North America is Expected to Dominate the Global Physician Dispensed Cosmeceuticals Market  

North America is expected to dominate the global physician-dispensed cosmeceuticals market within the forecast period due to the increasing awareness about cosmeceuticals, rising awareness about personal maintenance, and the presence of key players these factors boost the market. The growing awareness regarding the personal care among the aging population and the changing attitudes of middle-aged and older people in developing countries have increased the demand for cosmetics to eliminate the external signs of aging.

Moreover, the presence of key players is also boosting the growth of the market growth in this region. For example; in January 2021, Obagi Cosmeceuticals LLC launched Obagi Nu-Derm System, a wide-ranging skincare item particularly made for ordinary to dry skin to assist with restoring hyperpigmentation and change the presence of aging skin.

The Asia Pacific is the fastest-growing region in the global physician-dispensed cosmeceuticals market due to increasing options to maintain beauty and youthful outlook, rising preference to behold long-lasting youthful appearance and beauty, and growing demand for cosmeceuticals these factors boost the market.

For instance; as per the news published, on January 20^th, 2020; India-based pharmaceutical and cosmeceutical company pure nutrition launched a range of cosmetic products to capitalize on the potential of the country's US 8 billion Doller market.

News-

Young Pharmaceuticals Announced Exclusive North America Distribution Partnership with Lactobio for BAK Probiotic Skincare

On May 24^th, 2022; Youth Pharmaceuticals, Inc., the main supplier of physician-dispensed skincare products, announced an elite distribution agreement with Copenhagen-based Lactobio A/S, creator of BAK Probiotic Skincare. BAK Skincare has resulted from years of research based on the most recent study of the microbiome. Probiotic are living microscopic organisms that give a medical advantage and, for the Lactobio microbiologists, should clinically demonstrate a difference to be thought of as viable.

Topix Skin Health Launched New Phyto Multi-Correction Serum

On April 5^th, 2022; Topix Skin Health announced their first item release under their new business name, with the release of their physician-apportioned Phyto Multi-Correction Serum for sensitized skin. This calming serum, fueled by science, concentrated organic actives, and a dynamic antioxidant system that drives quick outcomes, gives equilibrium and correction to numerous skin concerns. Topix Skin Health will keep on developing its portfolio of proven drug-grade beauty, skincare, and health items that address purchasers' requirements through dermatologist-upheld science and proprietary, in-house created, licensed plans that offer clean, supportable, and strong ingredient combinations.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2022:	USD 8.58 Billion
Base year considered	2021
Forecast Period CAGR %:	8.72%
Market Size Expected in 2029:	USD 15.40 Billion
Tables, Charts & Figures:	175
Pages	300
Key Players/Companies	Biopelle, Inc, Jan Marini Skin Research, Inc., La Roche-Posay, Johnson & Johnson Consumer Inc., Obagi Cosmeceuticals LLC, Clarisonic, Solta Medical, GlaxoSmithKline plc., SkinCeuticals., PhytogenX, Inc., Clinique Laboratories, LLC., IS CLINICAL, ALLERGAN, and others
Segments Covered	By Product, By Application
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa